Existing Illumina sequencing Infrastructure

Closed Pre-Solicitation Posted

Solicitation number
PCA-NIAMS-08113
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Bethesda, Maryland 20892, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), intends to sole-source a firm-fixed-price purchase order to Illumina Inc. for the Illumina Protein Prep platform, a next-generation sequencing-based proteomics system, with capability statements due by 7:00 a.m. EST on July 30, 2026.

The platform delivers approximately 9,500 SOMAmer protein targets for broad protein discovery and relative quantification, proprietary dynamic range compression technology for detecting low-abundance proteins, and native integration with Illumina sequencing workflows and DRAGEN bioinformatics pipelines. NIAMS has determined that no other commercially available proteomics platform provides the same combination of protein target coverage, NGS-based scalability, SOMAmer chemistry, dynamic range compression, and seamless integration with existing Illumina systems, including the NovaSeq X Plus platform already in place at NIAMS. The system requires minimal additional software development or workflow customization.

Although NIH is pursuing sole-source award to Illumina Inc., small businesses—including 8(a) firms, service-disabled veteran-owned small businesses, HUBZone small businesses, small disadvantaged businesses, veteran-owned small businesses, and women-owned small businesses—may submit written capability statements demonstrating their ability to perform the requirement. Award is anticipated approximately ten days after the notice date unless the Government determines another organization has the capability to meet the requirement. Submit responses to Lynda.Cole@nih.gov. No pricing information is disclosed.

Notice text

Please see attached.

Files

File Type Posted
NOI-Illumina.docx DOCX document

Similar open opportunities

Opportunity Agency Set-aside Responses due
Intent to Sole Source - Medical/Scientific Instruments for the Department of Transfusion Medicine, NIH Clinical Center Bethesda, Maryland 20892, United States · NAICS 334516 National Institutes of Health No set-aside
Notice of Intent to Sole Source – AB Sciex LLC Maryland 20892, United States · NAICS 339112 NIH Clinical Center No set-aside
Notice of Intent: Maintenance Agreement for Tecan Fluent 780 robot Bethesda, Maryland 20892, United States · NAICS 811210 Office of Logisitics and Acquisition Operations No set-aside
Intent to Sole Source - BD FACSCanto II instrument Bethesda, Maryland 20892, United States · NAICS 334516 National Institutes of Health No set-aside
Notice of Intent: Measuring AAV9 vector DNA in mice tissue using qPCR Bethesda, Maryland 20892, United States · NAICS 541380 Office of Logisitics and Acquisition Operations No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity